Classical swine fever outbreak containment using antiviral supplementation: A potential alternative to emergency vaccination and stamping-out

Preventive Veterinary Medicine

Volumn 106, Issue 1, 2012, Pages 34-41

  Ribbens, S ^a,d   Goris, N ^b   Neyts, J ^c   Dewulf, J ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Okapi Sciences NV   (Belgium)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^d DGZ Vlaanderen ^*  (Belgium)

Author keywords

Antiviral; Classical swine fever; Control strategy; Stochastic model; Vaccination

Indexed keywords

ANTIVIRUS AGENT;

ANIMAL; ANIMAL DISEASE; ANIMAL EUTHANASIA; ARTICLE; CLASSICAL SWINE FEVER; EPIDEMIC; INFECTION CONTROL; MASS IMMUNIZATION; METHODOLOGY; RISK ASSESSMENT; RISK FACTOR; STATISTICS; SWINE;

ANIMALS; ANTIVIRAL AGENTS; CLASSICAL SWINE FEVER; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; EUTHANASIA, ANIMAL; MASS VACCINATION; RISK ASSESSMENT; RISK FACTORS; STOCHASTIC PROCESSES; SWINE;

SUIDAE;

EID: 84863878822     PISSN: 01675877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prevetmed.2012.03.002     Document Type: Article

References (35)

1. Backer J.A., Hagenaars T.J., van Roermund H.J.W., de Jong M.C.M. Modelling the effectiveness and risks of vaccination strategies to control classical swine fever epidemics. J. R. Soc. Interface 2009, 6:849-861.
2. Boklund A., Goldbach S.G., Uttenthal A., Alban L. Simulating the spread of classical swine fever virus between a hypothetical wild-boar population and domestic pig herds in Denmark. Prev. Vet. Med. 2008, 85:187-206.
3. Boklund A., Toft N., Alban L., Uttenthal A. Comparing the epidemiological and economic effects of control strategies against classical swine fever in Denmark. Prev. Vet. Med. 2009, 90:180-193.
4. Bouma A., De Smit A.J., de Jong M.C., De Kluijver E.P., Moormann R.J. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine 2000, 18:1374-1381.
5. Dewulf J., Koenen F., Laevens H., Mintiens K., de Kruif A. Airborne transmission of classical swine fever virus under experimental conditions. Vet. Rec. 2000, 147:735-738.
6. Dewulf J., Laevens H., Koenen F., Mintiens K., de Kruif A. An experimental infection with classical swine fever virus in pregnant sows: transmission of the virus, course of the disease, antibody response and effect on gestation. J. Vet. Med. 2001, B48:583-591.
7. Dewulf J., Laevens H., Koenen F., Mintiens K., de Kruif A. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs. Prev. Vet. Med. 2004, 65:121-133.
8. Dewulf J., Verloo D., Koenen F., Laevens H., Mintiens K., Ribbens S., de Kruif A. Demonstrating freedom of disease after an emergency vaccination campaign with an E2 sub unit marker vaccine against CSF: a simulation. Proceedings of the Conference of the Society for Veterinary Epidemiology and Preventive Medicine 2005, 68-78.
9. Dortmans J.C., Loeffen W.L., Weerdmeester K., van der Poel W.H., de Bruin M.G. Efficacy of intradermally administered E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus. Vaccine 2008, 26:1235-1242.
10. Elbers A.R., Stegeman A., Moser H., Ekker H.M., Smak J.A., Pluimers F.H. The classical swine fever epidemic 1997-1998 in The Netherlands: descriptive epidemiology. Prev. Vet. Med. 1999, 42:157-184.
11. Floegel-Niesmann G. Marker vaccines and compagnion diagnostic tests for classical swine fever. Vaccines for OIE List A and Emerging Animal Diseases 2003, 185-191. Krager, Basel. F. Brown, J. Roth (Eds.).
12. Goris N., Vandenbussche F., De Clercq K. Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock. Antivir. Res. 2008, 78:170-178.
13. Greiser-Wilke I., Moennig V. Vaccination against classical swine fever virus: limitations and new strategies. Anim. Health Res. Rev. 2004, 5:223-226.
14. Jalvingh A.W., Nielen M., Maurice H., Stegeman A.J., Elbers A.R., Dijkhuizen A.A. Spatial and stochastic simulation to evaluate the impact of events and control measures on the 1997-1998 classical swine fever epidemic in The Netherlands. I. Description of simulation model. Prev. Vet. Med. 1999, 42:271-295.
15. Karsten S., Rave G., Krieter J. Monte Carlo simulation of classical swine fever epidemics and control I. General concepts and description of the model. Vet. Microbiol. 2005, 108:187-198.
16. Kramer, M., Staubach, C., Koenen, F., Haegeman, A., Pol, F., Le Potier, M.-F., Greiser-Wilke, I., 2009. Scientific report submitted to EFSA on classical swine fever. http://www.efsa.europa.eu/en/supporting/doc/6e.pdf.
17. Laddomada A. Incidence and control of CSF in wild boar in Europe. Vet. Microbiol. 2000, 73:121-130.
18. Laevens H., Koenen F., Deluyker H., Berkvens D. An experimental infection with classical swine fever virus in weaner pigs. I. Transmission of the virus, course of the disease, and antibody response. Vet. Quart. 1998, 20:41-45.
19. Laevens H., Koenen F., Deluyker H., de Kruif A. Experimental infection of slaughter pigs with classical swine fever virus: transmission of the virus, course of the disease and antibody response. Vet. Rec. 1999, 145:243-248.
20. Leifer I., Hoffmann B., Höper D., Bruun Rasmussen T., Blome S., Strebelow G., Höreth-Böntgen D., Staubach C., Beer M. Molecular epidemiology of current classical swine fever virus isolates of wild boar in Germany. J. Gen. Virol. 2010, 91:2687-2697.
21. Meuwissen M., Horst S., Huirne R., Dijkhuizen A. A model to estimate the financial consequences of classical swine fever outbreaks: principles and outcomes. Prev. Vet. Med. 1997, 42:249-270.
22. Meuwissen M.P.M., Horst H.S., Huirne R.B.M., Dijkhuizen A.A. A model to estimate the financial consequences of classical swine fever outbreaks: principles and outcomes. Prev. Vet. Med. 1999, 42:249-270.
23. Morris R.S., Sanson R.L., Stern M.W., Stevenson M., Wilesmith J.W. Decision-support tools for foot and mouth disease control. Rev. Sci. Technol. 2002, 21:557-567.
24. Nielen M., Jalvingh A.W., Meuwissen M.P., Horst S.H., Dijkhuizen A.A. Spatial and stochastic simulation to evaluate the impact of events and control measures on the 1997-1998 classical swine fever epidemic in The Netherlands. II. Comparison of control strategies. Prev. Vet. Med. 1999, 42:297-317.
25. OIE, 2011. World Animal Health Information Database (WAHID) Interface. http://web.oie.int/wahis/public.php%3Fpage=home%26admin=0%26newlang=1.
26. Paeshuyse J., Chezal J.M., Froeyen M., Leyssen P., Dutartre H., Vrancken R., Canard B., Letellier C., Li T., Mittendorfer H., Koenen F., Kerkhofs P., De Clercq E., Herdewijn P., Puerstinger G., Gueiffier A., Chavignon O., Teulade J.C., Neyts J. The imidazopyrrolopyridine analogue AG110 is a novel, highly selective inhibitor of pestiviruses that targets the viral RNA-dependent RNA polymerase at a hot spot for inhibition of viral replication. J. Virol. 2007, 81:11046-11053.
27. Ribbens S., Dewulf J., Koenen F., Laevens H., de Kruif A. Transmission of classical swine fever. A review. Vet. Quart. 2004, 26:146-155.
28. Ribbens S., Dewulf J., Koenen F., Mintiens K., de Kruif A., Maes D. Type and frequency of contacts between Belgian pig herds. Prev. Vet. Med. 2009, 88:57-66.
29. Sanitel-Pigs Identification-and-Registration Data of Belgium Pig Herds and Livestock Movement 2006, Federal Agency of the Safety of the Food Chain, Belgium.
30. Stegeman J.A., Elbers A.R., Bouma A., de Jong M.C. Rate of inter-herd transmission of classical swine fever virus by different types of contact during the 1997-8 epidemic in The Netherlands. Epidemiol. Infect. 2002, 128:285-291.
31. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet. Microbiol. 2003, 96:367-384.
32. Vanthemsche P. Classical swine fever 1993-1994 in Belgium. Proceedings of the 8th Annual Meeting of the Dutch Society for Veterinary Epidemiology and Economics 1995, 25.
33. Vrancken R., Paeshuyse J., Haegeman A., Puerstinger G., Froeyen M., Herdewijn P., Kerkhofs P., Neyts J., Koenen F. Imidazo[4,5-c]pyridines inhibit the in vitro replication of the classical swine fever virus and target the viral polymerase. Antivir. Res. 2008, 77:114-119.
34. Vrancken R., Haegeman A., Paeshuyse J., Puerstinger G., Rozenski J., Wright M., Tignon M., Le Potier M.-F., Neyts J., Koenen F. Proof of concept for the reduction of classical swine fever infection in pigs by a novel viral polymerase inhibitor. J. Gen. Virol. 2009, 90:1335-1342.
35. Vrancken R., Haegeman A., Dewulf J., Paeshuyse J., Puerstinger G., Tignon M., Le Potier M.-F., Neyts J., Koenen F. The reduction of CSFV transmission to untreated pigs by the pestivirus inhibitor BPIP: a proof of concept. Vet. Microbiol. 2009, 139:365-368.